abstract |
The invention relates to methods of treating mesothelioma comprising administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule and at least one therapeutic agent selected from pemetrexed, cisplatin, paclitaxel, carboplatin, and docetaxel are provided. |